by Jayne Lehmann
P2 Diabetes Chat is for people with an interest in diabetes. Join Australian Credentialled Diabetes Educators Jayne Lehmann and Kirrily Chambers as they chat about diabetes issues of the day. Their combined 75+ yrs of professional and lived diabetes care, education and support experience brings a richness and depth to the chats and a healthy dose of humour, making it of interest to people living with diabetes and health professionals working with people with diabetes. N.B. We moved to a new hosting platform on 18/6/2022. Original date of publishing is in each podcast's introduction.
Language
🇺🇲
Publishing Since
6/18/2022
Email Addresses
1 available
Phone Numbers
0 available
May 19, 2024
<p>Type 1 diabetes is a family affair for Melbourne Endocrinologist Dr. Ben Nash. He's a long-time listener of the P2 Diabetes Chat program and made his first-time call to hosts, Jayne Lehmann and Kirrily Chambers, to chat about the real-world experience of Australians with type 1 diabetes who switched to the Omnipod pump. Ben reveals insights ... from the research and his family's experience with the Omnipod pump. This is a chat with a few surprises!</p> <p>This edition is sponsored by Insulet, makers of the Omnipod pump.</p>
November 29, 2023
<p>Chatsters (fans of P2 Diabetes Chat podcast!) know just how much P1 and P2 love to explore new diabetes technology! In this episode they get their chat on exploring the Omnipod DASH, an insulin delivery system for people with type 1 diabetes in Australia. </p> <p>As usual, Credentialled Diabetes Educators Jayne Lehmann and Kirrily Chambers deliver an episode with their honest opinions about Omnipods' features and experience supporting people with diabetes to use the device. As usual their humorous asides and the friendly banter see these very experienced gals of diabetes entertain as much as inform your understanding of another technology option in the diabetes treatment toolkit. Listen in to find out how the quirky episode title came about!</p> <p>This edition has been sponsored by Insulet.</p>
May 3, 2023
<p>This episode of P2 Diabetes Chat, Jayne Lehmann and Kirrily Chambers chat about continuous glucose monitoring. Novice Chatsters will enjoy the overview of the three systems available in Australia, their differences and the basics of what they bring to the lives of people with diabetes. Expert Chatsters will love the way P1 and P2 bring new meaning to analogies as education strategies. Of course, we can't forget Kirrily's Swiss Cheese theory of continuous glucose monitoring. This will go down as the most inspiring insight for 2023 in this year's 'Annual of Diabetes Self Management Education'! </p>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.